메뉴 건너뛰기




Volumn 18, Issue 6, 2008, Pages 1197-1211

Combined models for data from in vitro-in vivo correlation experiments

Author keywords

Controlled release; Convolution; Dissolution curve; IVIVC; One stage model fitting

Indexed keywords

GALANTAMINE;

EID: 57349146310     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543400802369061     Document Type: Article
Times cited : (8)

References (17)
  • 3
    • 0035152395 scopus 로고    scopus 로고
    • Evaluation of tests based on individual versus population modelling to compare dissolution curves
    • Comets, E., Mentré, F. (2001). Evaluation of tests based on individual versus population modelling to compare dissolution curves. Journal of Biopharmaceutical Statistics 11:107-123.
    • (2001) Journal of Biopharmaceutical Statistics , vol.11 , pp. 107-123
    • Comets, E.1    Mentré, F.2
  • 4
    • 0033618483 scopus 로고    scopus 로고
    • A new approach to modelling the relationship between in vitro and in vivo drug dissolution/absorption
    • Dunne, A. J., O'Hara, T., Devane, J. (1999). A new approach to modelling the relationship between in vitro and in vivo drug dissolution/absorption. Statistics in Medicine 18:1865-1876.
    • (1999) Statistics in Medicine , vol.18 , pp. 1865-1876
    • Dunne, A.J.1    O'Hara, T.2    Devane, J.3
  • 5
    • 19944416570 scopus 로고    scopus 로고
    • Deconvolution based approach for level A in vivo-in vitro correlation modelling: Statistical considerations
    • Dunne, A., Gaynor, C., Davis, J. (2005). Deconvolution based approach for level A in vivo-in vitro correlation modelling: statistical considerations. Clinical Research and Regulatory Affairs 22:1-14.
    • (2005) Clinical Research and Regulatory Affairs , vol.22 , pp. 1-14
    • Dunne, A.1    Gaynor, C.2    Davis, J.3
  • 6
    • 0000655208 scopus 로고    scopus 로고
    • Guidelines for dissolution testing of solid oral products
    • FIP
    • FIP (1996). Guidelines for dissolution testing of solid oral products. Drug Information Journal 30:1071-1084.
    • (1996) Drug Information Journal , vol.30 , pp. 1071-1084
  • 7
    • 0030806512 scopus 로고    scopus 로고
    • Convolution-based approaches for in vivo-in vitro correlation modelling
    • Gillespie, W. R. (1997). Convolution-based approaches for in vivo-in vitro correlation modelling. Advances in Experimental Medicine and Biology 423:53-65.
    • (1997) Advances in Experimental Medicine and Biology , vol.423 , pp. 53-65
    • Gillespie, W.R.1
  • 8
    • 0021842586 scopus 로고
    • Gastro-intestinal bioavailability: Determination of in vivo release profiles of solid dosage forms by deconvolution
    • Gillespie, W. R., Veng-Pedersen, P. (1985). Gastro-intestinal bioavailability: determination of in vivo release profiles of solid dosage forms by deconvolution. Biopharmaceutics and Drug Disposition 6:351-355.
    • (1985) Biopharmaceutics and Drug Disposition , vol.6 , pp. 351-355
    • Gillespie, W.R.1    Veng-Pedersen, P.2
  • 9
    • 1542724956 scopus 로고    scopus 로고
    • Interpretation and optimization of the dissolution specifications for a modified release product with an in vivo-in vitro correlation (IVIVC)
    • Hayes, S., Dunne, A., Smart, T., Davis, J. (2004). Interpretation and optimization of the dissolution specifications for a modified release product with an in vivo-in vitro correlation (IVIVC). Journal of Pharmaceutical Sciences 93:571-581.
    • (2004) Journal of Pharmaceutical Sciences , vol.93 , pp. 571-581
    • Hayes, S.1    Dunne, A.2    Smart, T.3    Davis, J.4
  • 10
    • 0036023387 scopus 로고    scopus 로고
    • Galantamine - a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease
    • Lilienfeld, S. (2002). Galantamine - a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease. CNS Drug Reviews 8:159-176.
    • (2002) CNS Drug Reviews , vol.8 , pp. 159-176
    • Lilienfeld, S.1
  • 12
    • 0034434385 scopus 로고    scopus 로고
    • Application of in vitro-in vivo correlations (IVIVC) in setting formulation release specifications
    • Modi, N. B., Lam, A., Lindemulder, E., Wang, B., Gupta, S. K. (2000). Application of in vitro-in vivo correlations (IVIVC) in setting formulation release specifications. Biopharmaceutics and Drug Disposition 21:321-326.
    • (2000) Biopharmaceutics and Drug Disposition , vol.21 , pp. 321-326
    • Modi, N.B.1    Lam, A.2    Lindemulder, E.3    Wang, B.4    Gupta, S.K.5
  • 16


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.